|
|
|
|
|
|
LEXOTAN®
|
|
Product Information (Abridged)
|
| |
|
| |
|
|
|
|
| |
| Properties |
| |
| LEXOTAN® (bromazepam) is a psychotropic drug. In |
| low dosage, it selectively reduces tension and anxiety. |
| |
| Indications |
| |
| LEXOTAN® is indicated for the treatment of all |
| conditions arising from emotional over-reaction to |
| stressful situations and conflicts: |
| |
| Tension and anxiety states |
| Anxious, agitated depressive reactions |
|
| Nervousness, stress and overstrain, minor agitation, autonomic dysfunction. |
| Phobias, obsessive and compulsive neuroses. |
| As adjuvant in functional disturbances in the cardiovascular, respiratory gastrointenstinal and genitourinary systems. |
| Psychosomatic disorders: gastric and duodenal ulcer, ulcerative colitis, asthma etc. |
| Anxious – depressive reactions in chronic somatic illness. |
| |
| Dosage |
| |
|
Average dose for all patient therapy: 1.5 – 3mg three times daily, severe cases, especially in hospital: 6 – 12mg two or three times daily.
These are average recommendations, and dosage should be individually determined. Treatment of out patients in general begins with the lowest dose, gradually increasing if necessary to the optimum level. After about three to six weeks, according to progress in therapy, dosage can usually be gradually reduced and then stopped.
|
| |
| Side effects |
| |
|
LEXOTAN® is well tolerated. Side effects such as fatigue, drowsiness and rarely muscle weakness can occur with high doses.
|
| |
| Contraindication |
| |
| Myaesthenia gravis |
| |
| Precautions |
| |
|
Elderly and debilitated patients require cautious dosage because of individual variations in sensitivity to psychotropic medication. If LEXOTAN® is combined with other centrally acting drugs such as neuroleptics, tranquillizers, antidepressants, hypnotics, analgesics and anaesthetics, it should be borne in mind that pronounced sedation may result. This intensification can sometimes be exploited therapeutically. With LEXOTAN® as with other psychoactice substances, patients should avoid taking alcohol while under the influence of the treatment, since the individual response cannot be forseen. Like all medicament of this type, LEXOTAN® may modify the patient’s reactions (driving ability, behaviour in traffic etc) to a varying extent depending on dosage, administration and individual susceptibility.
|
| |
| Packs |
| |
| Tablets (scored) 1.5mg - 30, 500 |
| Tablets (Scored) 3.0mg - 30, 500 |
| |
| |
|
|
|
|